Guest Post by David Kliff, Editor, Diabetic Investor
This weekend, the most dedicated people in diabetes will gather in Baltimore for the AADE conference. Year after year, these amazing people gather to see all the latest toys in the toy chest, learn about all the new drugs, and share insights into how they are impacting the lives of the patients they work with.

Would you be more open to prescribing a GLP-1 Inhibitor if there was an oral product rather than an injectable? Follow the link to share your opinion and see what your colleagues think.

According to a recent study, frequently consuming meat, poultry, or fish cooked at high temperatures increases the risk for hypertension by how much?

A. 11%
B. 17%
C. 23%
D. 25%
E. 38%

Follow the link for the answer.

Little or no excess risk of death, MI, stroke for those with five risk-factor variables within target ranges

Physicians can stress the factors in a patient's control and change messaging about the condition

Gene variants do not modify the associations of 25(OH)D with lipids

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality

In my editor’s desk on Saturday I used the moniker “insulin dependent type 2 diabetes patients” describing an article our intern had done on adding an SGLT-2 Inhibitor to insulin use. I got some feedback from some of you as to my choice of words, and was this a new …

Teach patients what DKA is and how to prevent it. Include in your teaching that glucose can be normal or only slightly elevated and it can still happen. Teach that having an illness and/or dehydration increases this risk.

Stanley Schwartz, MD, FACP, FACE is an Affiliate of the Main Line Health System, and an Emeritus Associate Professor of Medicine at the University of Pennsylvania, currently in a private practice in Ardmore, Pa.  Dr. Schwartz received his MD in 1973 from the University of Chicago in Chicago, Illinois. He then completed his residency at the University of Pennsylvania, followed by a fellowship in endocrinology and metabolism at the University of Chicago.